Direct comparison of the dynamics of IL-25- and 'allergen'-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model

Clinical and Experimental Allergy

Volumn 44, Issue 5, 2014, Pages 765-777

  Yao, X J ^a   Huang, K W ^b   Li, Y ^b   Zhang, Q ^a   Wang, J J ^c   Wang, W ^b,c   Liu, J ^c   Lv, Z ^c   An, Y Q ^c   Ding, Y Z ^c   Corrigan, C J ^d   Sun, Y C ^a   Ying, S ^c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Asthma; IL 25; IL 25 receptor; Murine model; Pathogenesis; Remodelling

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; COLLAGEN; EOTAXIN; INTERLEUKIN 33; INTERLEUKIN 8; MATRIX PROTEIN; CHEMOKINE; CYTOKINE; D17WSU104E PROTEIN, MOUSE; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE; SCLEROPROTEIN;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL ASTHMA; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT ALLERGY; SMOOTH MUSCLE FIBER; TH2 CELL; ANGIOGENESIS; ANTIBODY BLOOD LEVEL; CELL HYPERPLASIA; CELL INFILTRATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GOBLET CELL; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LOEFFLER PNEUMONIA; LUNG PARENCHYMA; OOCYTE; ANIMAL; ASTHMA; DISEASE MODEL; EOSINOPHILIA; HYPERPLASIA; HYPERTROPHY; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; SMOOTH MUSCLE;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ASTHMA; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GOBLET CELLS; HYPERPLASIA; HYPERTROPHY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKINS; LUNG; MICE; MUSCLE, SMOOTH;

EID: 84921898720     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12298     Document Type: Article

References (39)

1. Fort MM, Cheung J, Yen D et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15:985-95.
2. wHurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169:443-53.
3. Pan G, French D, Mao W et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001; 167:6559-67.
4. Kim MR, Manoukian R, Yeh R et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002; 100:2330-40.
5. Neill DR, Wong SH, Bellosi A et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-70.
6. Angkasekwinai P, Park H, Wang YH et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204:1509-17.
7. Ballantyne SJ, Barlow JL, Jolin HE et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120:1324-31.
8. Gregory LG, Jones CP, Walker SA et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013; 68:82-90.
9. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204:1837-47.
10. Corrigan CJ, Wang W, Meng Q et al. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci U S A 2011; 108:1579-84.
11. Corrigan CJ, Wang W, Meng Q et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 2011; 128:116-24.
12. Wang W, Fan YQ, Lv Z et al. Interleukin-25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL-17RB, but not IL-17RA. Clin Exp Allergy 2012; 42:1604-14.
13. Lajoie-Kadoch S, Joubert P, Létuvé S et al. TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1238-46.
14. Létuvé S, Lajoie-Kadoch S, Audusseau S et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006; 117:590-6.
15. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004; 34:497-507.
16. Sharkhuu T, Matthaei KI, Forbes E et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006; 36:1575-83.
17. Jonasson S, Hedenstierna G, Hedenström H, Hjoberg J. Comparisons of effects of intravenous and inhaled methacholine on airway physiology in a murine asthma model. Respir Physiol Neurobiol 2009; 165:229-36.
18. Riesenfeld E, Allen GB, Bates JH et al. The temporal evolution of airways hyperresponsiveness and inflammation. J Allergy Ther 2012; 1:1-7.
19. Rickel EA, Siegel LA, Yoon BR et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008; 181:4299-310.
20. Ying S, Meng Q, Smith S, Larche M, Kay AB. EG2 strong+ and Congo red+ but not EG2 weak+ or MBP+ cells, reliably represent the human eosinophil phenotype in blood and tissues. Allergy Clin Immunol Int 2002; 14:64-9.
21. Ecker RC, Rogojanu R, Streit M, Oesterreicher K, Steiner GE. An improved method for discrimination of cell populations in tissue sections using microscopy-based multicolor tissue cytometry. Cytometry 2006; 69:119-23.
22. Wang C, Shu SY, Guo Z et al. Immunohistochemical localization of mu opioid receptor in the marginal division with comparison to patches in the neostriatum of the rat brain. J Biomed Sci 2011; 18:34-43.
23. Szczypka M, Ploch S, Obmińska-Mrukowicz B. Modulation of Th1/Th2 cytokine production by selective and nonselective phosphodiesterase inhibitors administered to mice. Pharmacol Rep 2012; 64:179-84.
24. Leow-Dyke S, Allen C, Denes A et al. Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation 2012; 9:230-40.
25. Kim SE, Kim JH, Min BH, Bae YM, Hong ST, Choi MH. Crude extracts of Caenorhabditis elegans suppress airway inflammation in a murine model of allergic asthma. PLoS ONE 2012; 7:e35447.
26. Suzukawa M, Morita H, Nambu A et al. Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J Immunol 2012; 189:3641-52.
27. Shibui A, Shimura E, Nambu A et al. Th17 cell-derived IL-17 is dispensable for B cell antibody production. Cytokine 2012; 59:108-14.
28. Swaidani S, Bulek K, Kang Z et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009; 182:1631-40.
29. Kanda A, Driss V, Hornez N et al. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. J Allergy Clin Immunol 2009; 124:573-82.
30. Flood-Page P, Menzies-Gow A, Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003; 112:1029-36.
31. Imaoka H, Hoshino T, Takei S et al. Effects of thioredoxin on established airway remodelling in a chronic antigen exposure asthma model. Biochem Biophys Res Commun 2007; 360:525-30.
32. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodelling in asthma: new insights. J Allergy Clin Immunol 2003; 111:215-25.
33. Petersen BC, Lukacs NW. IL-17A and IL-25: therapeutic targets for allergic and exacerbated asthmatic disease. Future Med Chem 2012; 7:833-6.
34. Stassen M, Schmitt E, Bopp T. From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci 2012; 1247:56-8.
35. Barlow JL, Peel S, Fox J et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immuno 2013; 132:933-41.
36. Vanoirbeek JAJ, Rinaldi M, De Vooght V et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 2010; 42:96-104.
37. Manali ED, Moschos C, Triantafillidou C et al. Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BMC Pulm Med 2011; 11:33-45.
38. Kouzaki H, Tojima I, Kita H, Shimizu T. Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells. Am J Respir Cell Mol Biol 2013; 49:741-50.
39. Collison A, Hatchwell L, Verrills N et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 2013; 19:232-7.